Get all your news in one place.
100's of premium titles.
One app.
Start reading
Daily Record
Daily Record
National
Hannah Carmichael

Advice published for three new medical treatments in Scotland

Three new medicines have had advice published for use in conditions including a rare and fatal genetic condition affecting young children and a form of leukaemia.

The Scottish Medicines Consortium (SMC) issued the advice for atidarsagene autotemcel (Libmeldy), venetoclax (Venclyxto) and upadacitinib (Rinvoq).

Libmeldy, a highly specialised stem cell treatment given as a single dose, can be used to treat children with a rare genetic condition called metachromatic leukodystrophy (MLD).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.